Tighter Compounding Pharmacy Oversight Advances in Senate

Legislation to broaden federal regulation of compounding pharmacies like the one linked to last year’s meningitis deaths may reach President Barack Obama’s desk in days after clearing a procedural hurdle in the U.S. Senate.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.